The role of
Adult
Aged
Aged, 80 and over
Female
Fluorodeoxyglucose F18
/ metabolism
Follow-Up Studies
Humans
Leiomyosarcoma
/ diagnostic imaging
Liposarcoma
/ diagnostic imaging
Male
Middle Aged
Neoplasm Recurrence, Local
/ diagnostic imaging
Positron Emission Tomography Computed Tomography
/ methods
Prognosis
Radiopharmaceuticals
/ metabolism
Retroperitoneal Neoplasms
/ diagnostic imaging
Retrospective Studies
Survival Rate
PET scan
retroperitoneal
soft tissue tumor
Journal
Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
24
12
2020
accepted:
27
12
2020
pubmed:
15
1
2021
medline:
11
3
2021
entrez:
14
1
2021
Statut:
ppublish
Résumé
The role of Patients with the above histological subtypes in three participating institutions with preoperative Of the total 58 patients, final pathological subtype was DDLPS in 44 (75.9%) patients and LMS in 14 (24.1%) patients. The mean SUVmax was 8.7 with a median 7.1 (range, 2.2-33.9). The tumors were graded I, II, III in 6 (10.3%), 35 (60.3%), and 17 (29.3%) patients, respectively. There was an association of higher histological grade with higher SUVmax (r There is a correlation between SUVmax and pathologic tumor grade; increasing SUVmax was associated with worse OS and RFS, providing a preoperative noninvasive surrogate marker of tumor grade and biological behavior.
Sections du résumé
BACKGROUND
BACKGROUND
The role of
METHODS
METHODS
Patients with the above histological subtypes in three participating institutions with preoperative
RESULTS
RESULTS
Of the total 58 patients, final pathological subtype was DDLPS in 44 (75.9%) patients and LMS in 14 (24.1%) patients. The mean SUVmax was 8.7 with a median 7.1 (range, 2.2-33.9). The tumors were graded I, II, III in 6 (10.3%), 35 (60.3%), and 17 (29.3%) patients, respectively. There was an association of higher histological grade with higher SUVmax (r
CONCLUSION
CONCLUSIONS
There is a correlation between SUVmax and pathologic tumor grade; increasing SUVmax was associated with worse OS and RFS, providing a preoperative noninvasive surrogate marker of tumor grade and biological behavior.
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1081-1087Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Brennan MF, Antonescu CR, Moraco N, Singer S. Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg. 2014;260(3):416-421, discussion 21-2.
Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27(1):31-37.
Tan MCB, Brennan MF, Kuk D, et al. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg. 2016;263(3):593-600.
Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the Multi-institutional Collaborative RPS Working Group. Ann Surg. 2016;263(5):1002-1009.
Bonvalot S, Gronchi A, Le Pechoux C, et al. STRASS (EORTC 62092): a phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. J Clin Oncol. 2019;37(15_suppl):11001.
Trans-Atlantic RPSWG. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol. 2015;22(1):256-263.
Bronstein Y, Ng CS, Rohren E, et al. PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. Am J Roentgenol. 2012;198(4):902-908.
Chandra P, Purandare N, Shah S, et al. Diagnostic accuracy and impact of fluorodeoxyglucose positron emission tomography/computed tomography in preoperative staging of cutaneous malignant melanoma: results of a prospective study in Indian population. World J Nucl Med. 2017;16(4):286-292.
Hwang SY, Warrier S, Thompson S, Davidson T, Yang JL, Crowe P. Safety and accuracy of core biopsy in retroperitoneal sarcomas. Asia Pac J Clin Oncol. 2016;12(1):e174-e178.
Wilkinson MJ, Martin JL, Khan AA, Hayes AJ, Thomas JM, Strauss DC. Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival. Ann Surg Oncol. 2015;22(3):853-858.
Young R, Snow H, Hendry S, et al. Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single-centre study. ANZ J Surg. 2020;90(4):497-502.
van Houdt WJ, Raut CP, Bonvalot S, Swallow CJ, Haas R, Gronchi A. New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration. Curr Opin Oncol. 2019;31(4):310-316.
R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015.
Rhu J, Hyun SH, Lee KH, et al. Maximum standardized uptake value on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improves outcome prediction in retroperitoneal liposarcoma. Sci Rep. 2019;9(1):6605.
Tattersall HL, Callegaro D, Ford SJ. Gronchi A. Staging, nomograms and other predictive tools in retroperitoneal soft tissue sarcoma. Chin Clin Oncol. 2018;7(4):36.
Raut CP, Callegaro D, Miceli R, et al. Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG. Clin Cancer Res. 2019;25(8):2664-2671.
Tseng W, Martinez SR, Tamurian RM, Borys D, Canter RJ. Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma. J Surg Res. 2012;172(1):123-130.
Almond LM, Tirotta F, Tattersall H, et al. Diagnostic accuracy of percutaneous biopsy in retroperitoneal sarcoma. Br J Surg. 2019;106(4):395-403.
Tirotta F, Morosi C, Hodson J, et al. Improved biopsy accuracy in retroperitoneal dedifferentiated liposarcoma. Ann Surg Oncol. 2020;27(11):4574-4581.
Schneider N, Strauss DC, Smith MJ, et al. The adequacy of core biopsy in the assessment of smooth muscle neoplasms of soft tissues: implications for treatment and prognosis. Am J Surg Pathol. 2017;41(7):923-931.
Ikoma N, Torres KE, Somaiah N, et al. Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes. Ann Surg Oncol. 2015;22(4):1068-1072.
Alford S, Choong P, Chander S, et al. Value of PET scan in patients with retroperitoneal sarcoma treated with preoperative radiotherapy. Eur J Surg Oncol. 2012;38(2):176-180.
Benz MR, Tchekmedyian N, Eilber FC, Federman N, Czernin J, Tap WD. Utilization of positron emission tomography in the management of patients with sarcoma. Curr Opin Oncol. 2009;21(4):345-351.
Evilevitch V, Weber WA, Tap WD, et al. Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas. Clin Cancer Res. 2008;14(3):715-720.
Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995;221(2):185-195.
Bagaria SP, Gabriel E, Mann GN. Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol. 2018;117(1):62-68.
Gronchi A, van Houdt WJ, et al. A randomized phase III study of neoadjuvant chemotherapy followed by surgery versus surgery alone for patients with High Risk RetroPeritoneal Sarcoma (STRASS 2). http://clinicaltrials.gov/ct/show/NCT04031677
Kitao T, Shiga T, Hirata K, et al. Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas. Ann Nucl Med. 2019;33(1):22-31.